ITIC

Investors Title is a high-quality, conservatively run microcap title insurer (ITIC/NITIC underwriting is 90.2% of revenue per the MD&A) with a genuinely fortress balance sheet: liabilities/equity of just 0.35x, $268M of equity against $363M of assets, and $267M of retained earnings. FY2025 was a clear cyclical recovery year — net income rose 13.2% to $35.2M and diluted EPS 13.0% to $18.57, off the 2023 trough (NI $21.7M) that the housing/mortgage freeze inflicted. The MD&A is explicit that this is a volume-driven, operating-leverage business: fixed costs mean earnings amplify in both directions with real estate and mortgage activity, so falling rates reviving purchase and refinance volume is the real upside lever.

The problem is that quality is already in the price. At $281.21 the stock trades at ~15.1x FY2025 EPS and roughly 2.0x book value ($268M equity / 1.89M shares ≈ $142/share) against a merely-average 13.1% ROE. That is a full multiple for a deeply cyclical earner that has swung from $67.0M net income in the 2021 refi boom to $21.7M in 2023 — FY2025's result looks closer to mid-cycle than trough, so you are not buying a depressed number cheaply. Management's own capital actions are cautious: no buybacks in FY2025 despite 413,177 shares still authorized, dividends paid down 33.3%, and cash down 15.5%.